HB 4276: Impose various regulations on pharmacies
Introduced March 14, 2023
Official text and analysis
Human services: medical services; Medicaid managed care contract with pharmacy benefit manager; regulate, and require reporting.
Tags: Big Pharma, Regulations
Sponsor: Alabas Farhat
Cosponsors: Abraham Aiyash, Veronica Paiz, Erin Byrnes, Kara Hope, Ranjeev Puri, Jason Morgan, Donavan McKinney, Tyrone Carter, Jimmie Wilson, Kevin Coleman, Regina Miller, Jasper Martus, Emily Dievendorf, Kimberly Edwards, Stephanie Young, Brenda Carter, Laurie Pohutsky, Jim Haadsma, Lori Stone, Penelope Tsernoglou, Mike McFall, Tullio Liberati, Cynthia Neeley, Amos O'Neal, Kristian Grant, Jaime Churches, Denise Mentzer, Jason Hoskins, Sharon MacDonell, Julie Brixie, Matt Koleszar, Helena Scott, Rachel Hood, Jennifer Conlin, Christine Morse, Curtis VanderWall, Karen Whitsett
Referred to House Health Policy Committee
Votes on this bill
10/25/23 House roll call vote #410 On passage: Passed 105 – 4 (See how they voted)
11/09/23 Senate roll call vote #731 On passage: Passed 36 – 0 (See how they voted)
HB 4316: Allow pharmacists to order and administer vaccines
Introduced March 21, 2023
Official text and analysis
Health occupations: pharmacists; pharmacists to order and administer vaccines and laboratory tests under certain circumstances; allow. Amends secs. 9204 & 17707 of 1978 PA 368 (MCL 333.9204 & 333.17707) & adds secs. 17724 & 17724a.
Tags: Big Pharma, Civil Liberties
Sponsor: Alabas Farhat
Cosponsors: none
Referred to House Health Policy Committee
HB 4409: Require drug companies file report on costs and other information
Introduced April 13, 2023
Official text and analysis
Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department.
Tags: Big Pharma
Sponsor: Samantha Steckloff
Cosponsors: Christine Morse, Rachel Hood, Dylan Wegela, Mike McFall, Natalie Price, Cynthia Neeley, Erin Byrnes, Penelope Tsernoglou, Veronica Paiz, Emily Dievendorf, Regina Miller, Noah Arbit, Tyrone Carter, Tullio Liberati, Regina Weiss, Jim Haadsma, Kara Hope, Felicia Brabec, Jimmie Wilson, Abraham Aiyash
Referred to House Health Policy Committee
HB 5202: Expand liability of drug makers for not disclosing risks
Introduced October 24, 2023
Official text and analysis
Consumer protection: unfair trade practices; liability for inaccurate representations concerning risks of certain drugs, medications, and supplements; clarify.
Tags: Big Pharma, Civil Law
Sponsor: William Snyder
Cosponsors: Kelly Breen, Penelope Tsernoglou, Kara Hope, Erin Byrnes, Carrie Rheingans, Rachel Hood, Natalie Price, Jason Morgan, Tullio Liberati, Samantha Steckloff, Mike McFall, Sharon MacDonell, Jimmie Wilson
Referred to House Regulatory Reform Committee
HB 5259: Expand health registry to include reporting adverse events of vaccinations
Introduced October 26, 2023
Official text and analysis
Health: immunizations; access to the Michigan care improvement registry; restrict and expand the registry to include the reporting of adverse events resulting from immunizing agents.
Tags: Big Pharma, Health, Oversight
Sponsor: Ken Borton
Cosponsors: Alicia St. Germaine, Robert Bezotte, Jay DeBoyer, Brian BeGole, Joseph Aragona, Gina Johnsen, Angela Rigas, Rachelle Smit, Steve Carra, Brad Paquette, William Bruck, Jaime Greene
Referred to House Government Operations Committee
HB 5260: Allow prescription of "off-label" drugs (not approved for prescribed usage by the FDA)
Introduced October 26, 2023
Official text and analysis
Health: pharmaceuticals; authority to prescribe off-label prescriptions; provide for.
Tags: Big Pharma, Civil Liberties, Health, Drugs
Sponsor: John Roth
Cosponsors: Alicia St. Germaine, Robert Bezotte, Jay DeBoyer, Brian BeGole, Joseph Aragona, Gina Johnsen, Angela Rigas, Rachelle Smit, Steve Carra, Brad Paquette, Ken Borton, William Bruck, Jaime Greene
Referred to House Government Operations Committee
HB 5350: Prohibit drug makers from making certain contracts with pharmacies
Introduced November 14, 2023
Official text and analysis
Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit.
Tags: Big Pharma, Regulations, Health, Drugs
Sponsor: Alabas Farhat
Cosponsors: Carrie Rheingans, Erin Byrnes, Jimmie Wilson, Penelope Tsernoglou, Philip Skaggs, Jasper Martus, Jim Haadsma, Helena Scott, Donavan McKinney, Brenda Carter, Regina Miller, Jennifer Conlin, Carol Glanville, Cynthia Neeley, Gina Johnsen, Rachel Hood, Emily Dievendorf, Karen Whitsett
Referred to House Health Policy Committee
SB 27: Require insurers provide equal benefits for mental illness as real illness
Introduced January 18, 2023
Official text and analysis
Insurance: health insurers; equitable coverage for behavioral health and substance use disorder treatment; provide for.
Tags: Big Pharma, Leftism
Sponsor: Sara Anthony
Cosponsors: Paul Wojno, Erika Geiss, Mary Cavanagh, Sam Singh, Stephanie Chang
Referred to Senate Health Policy Committee
Votes on this bill
10/18/23 Senate roll call vote #544 On passage: Passed 35 – 3 (See how they voted)
SB 410: Allow some lawsuits against drug-makers, removing ban on suing FDA-approved drugs
Introduced June 27, 2023
Official text and analysis
Torts: product liability; limitation on liability for drugs that have been approved by federal Food and Drug Administration; rescind.
Tags: Big Pharma, Drugs
Sponsor: Jeff Irwin
Cosponsors: none
Referred to Senate Civil Rights, Judiciary, and Public Safety Committee
Votes on this bill
10/18/23 Senate roll call vote #547 On passage: Passed 30 – 8 (See how they voted)
11/08/23 House roll call vote #519 On passage: Passed 79 – 30 (See how they voted)
SB 483: New law to create a board to establish price controls on drugs
Introduced September 12, 2023
Official text and analysis
Health: pharmaceuticals; prescription drug cost and affordability review act; create.
Tags: Big Pharma, Special Interest Deal, Health, Drugs
Sponsor: Darrin Camilleri
Cosponsors: Kristen McDonald Rivet, Veronica Klinefelt, Jeremy Moss, John Cherry, Rosemary Bayer, Dayna Polehanki, Mallory McMorrow, Paul Wojno, Sylvia Santana, Mary Cavanagh, Sam Singh, Stephanie Chang, Erika Geiss, Winnie Brinks, Sue Shink, Jeff Irwin, Sara Anthony
Referred to Senate Finance, Insurance, and Consumer Protection Committee
Votes on this bill
10/04/23 Senate roll call vote #493 Amendment to prohibit former board members from exercising First Amendment rights for 5 years: Passed 37 – 0 (See how they voted)
10/04/23 Senate roll call vote #494 Amendment to prohibit governor's donors from being appointed: Failed 17 – 20 (See how they voted)
10/04/23 Senate roll call vote #495 Amendment to require 1 board member be a "one who advocates for patients": Failed 17 – 20 (See how they voted)
10/04/23 Senate roll call vote #496 Amendment to sunset bill after 3 years: Failed 17 – 20 (See how they voted)
10/04/23 Senate roll call vote #497 Amendment to consider the cost of manufacturing the drug whose price the bill would control: Failed 17 – 20 (See how they voted)
10/04/23 Senate roll call vote #498 On passage: Passed 20 – 17 (See how they voted)
SB 484: New law to create a board to establish price controls on drugs
Introduced September 12, 2023
Official text and analysis
Insurance: health insurers; compliance with the prescription drug cost and affordability review act; require.
Tags: Big Pharma, Health, Drugs
Sponsor: Veronica Klinefelt
Cosponsors: Darrin Camilleri, Kristen McDonald Rivet, Jeremy Moss, John Cherry, Rosemary Bayer, Dayna Polehanki, Mallory McMorrow, Paul Wojno, Sylvia Santana, Mary Cavanagh, Sam Singh, Stephanie Chang, Erika Geiss, Winnie Brinks, Sue Shink, Jeff Irwin, Sara Anthony
Referred to Senate Finance, Insurance, and Consumer Protection Committee
Votes on this bill
10/04/23 Senate roll call vote #499 On passage: Passed 20 – 17 (See how they voted)
SB 485: New law to create a board to establish price controls on drugs
Introduced September 12, 2023
Official text and analysis
Human services: medical services; compliance with the prescription drug cost and affordability review act; require.
Tags: Big Pharma, Health, Drugs
Sponsor: Kristen McDonald Rivet
Cosponsors: Darrin Camilleri, Veronica Klinefelt, Jeremy Moss, John Cherry, Rosemary Bayer, Dayna Polehanki, Mallory McMorrow, Paul Wojno, Sylvia Santana, Mary Cavanagh, Sam Singh, Stephanie Chang, Erika Geiss, Winnie Brinks, Sue Shink, Jeff Irwin, Sara Anthony
Referred to Senate Finance, Insurance, and Consumer Protection Committee
Votes on this bill
10/04/23 Senate roll call vote #500 On passage: Passed 20 – 17 (See how they voted)
SB 530: Impose medical reimbursement price controls with higher reimbursements for metro Detroit
Introduced September 26, 2023
Official text and analysis
Insurance: no-fault; treatment and services for injuries; revise limitations on charges.
Tags: Big Pharma, Special Interest Deal, Transportation, Health, Insurance
Sponsor: Mary Cavanagh
Cosponsors: Sara Anthony, John Damoose, Jeff Irwin, Dayna Polehanki, Mallory McMorrow, Stephanie Chang, Erika Geiss, Sam Singh, Paul Wojno, Rosemary Bayer, Veronica Klinefelt, Winnie Brinks, Jeremy Moss, Darrin Camilleri, Sue Shink, Jon Bumstead, Rick Outman
Referred to Senate Finance, Insurance, and Consumer Protection Committee
Votes on this bill
10/19/23 Senate roll call vote #572 Republican amendment: Failed 16 – 21 (See how they voted)
10/19/23 Senate roll call vote #573 On passage: Passed 23 – 14 (See how they voted)
SB 531: Impose medical reimbursement price controls with higher reimbursements for metro Detroit
Introduced September 26, 2023
Official text and analysis
Insurance: no-fault; cross-reference to amended section of the insurance code; revise.
Tags: Big Pharma, Special Interest Deal, Transportation, Health, Insurance
Sponsor: Sara Anthony
Cosponsors: Mary Cavanagh, John Damoose, Jeff Irwin, Dayna Polehanki, Mallory McMorrow, Stephanie Chang, Erika Geiss, Sam Singh, Paul Wojno, Rosemary Bayer, Veronica Klinefelt, Winnie Brinks, Jeremy Moss, Darrin Camilleri, Sue Shink, Jon Bumstead, Rick Outman
Referred to Senate Finance, Insurance, and Consumer Protection Committee
Votes on this bill
10/19/23 Senate roll call vote #574 On passage: Passed 23 – 14 (See how they voted)
SB 563: Create a program for wholesale importation of drugs from Canada
Introduced October 5, 2023
Official text and analysis
Health: pharmaceuticals; program for the wholesale importation of pharmaceuticals from Canada; provide for.
Tags: Big Pharma, Drugs
Sponsor: Ruth Johnson
Cosponsors: Michele Hoitenga, Jim Runestad, Jeff Irwin, Kevin Hertel, John Damoose, Jonathan Lindsey, Rick Outman
Referred to Senate Health Policy Committee
SB 574: Create Tricare premium reimbursement program (veterans coverage) for WhitmerCare
Introduced October 10, 2023
Official text and analysis
Military affairs: other; Tricare premium reimbursement program; create.
Tags: Big Pharma, Special Interest Deal, Veterans / Military, Health
Sponsor: Sam Singh
Cosponsors: Kevin Hertel, Sara Anthony, Paul Wojno, Erika Geiss
Referred to Senate Appropriations Committee
SB 592: Prohibit state lawsuits related to various opioid settlements
Introduced October 17, 2023
Official text and analysis
Civil procedure: civil actions; civil actions against certain opioid litigation settlement defendants; prohibit.
Tags: Big Pharma, Civil Law, Drugs
Sponsor: Rosemary Bayer
Cosponsors: none
Referred to Senate Civil Rights, Judiciary, and Public Safety Committee
Votes on this bill
10/25/23 Senate roll call vote #592 On passage: Passed 38 – 0 (See how they voted)
11/08/23 House roll call vote #521 On passage: Passed 104 – 5 (See how they voted)
